Structural and biochemical characteristics of arterial stiffness in patients with atherosclerosis and in healthy subjects

Hypertension Research

Volumn 35, Issue 10, 2012, Pages 1032-1037

  Zagura, Maksim ^a,b   Kals, Jaak ^a,b,c   Serg, Martin ^b   Kampus, Priit ^a,b   Zilmer, Mihkel ^a,b   Jakobson, Meelis ^c   Unt, Eve ^b,c   Lieberg, Jüri ^b,c   Eha, Jaan ^b  

^a Faculty of Medicine   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

arterial stiffness; osteopontin; oxidized LDL; peripheral arterial disease

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OSTEOPONTIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PENTOXIFYLLINE;

ADULT; ANGIOGRAPHY; APPLANATION TONOMETER; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; BIOCHEMISTRY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN BLOOD LEVEL; PULSE WAVE;

AGED; ATHEROSCLEROSIS; GLOMERULAR FILTRATION RATE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OSTEOPONTIN; OXIDATIVE STRESS; PERIPHERAL ARTERIAL DISEASE; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84867211270     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.88     Document Type: Article

References (28)

1. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. European Network for non-invasive investigation of large arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605.
2. Boutouyrie P, Tropeano A, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39: 10-15.
3. Agabiti-Rosei E, Muiesan M. Carotid atherosclerosis, arterial stiffness and stroke events. Adv Cardiol 2007; 44: 173-186.
4. Van Popele N, Grobbee D, Bots M, Asmar R, Topouchian J, Reneman R, Hoeks A, van der Kuip D, Hofman A, Witteman J. Association between arterial stiffness and atherosclerosis: the Rotterdam study. Stroke 2001; 32: 454-460.
5. Kurata M, Okura T, Kumon Y, Tagawa M, Watanabe H, Nakahara T, Miyazaki T, Higaki J, Nose M. Plasma thrombin-cleaved osteopontin elevation after carotid artery stenting in symptomatic ischemic stroke patients. Hypertens Res 2012; 35: 207-212.
6. Scatena M, Liaw L, Giachelli C. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 2302-2309.
7. Ohmori R, Momiyama Y, Taniguchi H, Takahashi R, Kusuhara M, Nakamura H, Ohsuzu F. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003; 170: 333-337.
8. Minoretti P, Falcone C, Calcagnino M, Emanuele E, Buzzi M, Coen E, Geroldi D. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. Eur Heart J 2006; 27: 802-807.
9. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678.
10. Kals J, Kampus P, Kals M, Zilmer K, Kullisaar T, Teesalu R, Pulges A, Zilmer M. Impact of oxidative stress on arterial elasticity in patients with atherosclerosis. Am J Hypertens 2006; 19: 902-908.
11. Madamanchi N, Vendrov A, Runge M. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 29-38.
12. Hirsch A, Haskal Z, Hertzer N, Bakal C, Creager M, Halperin J, Hiratzka L, Murphy W, Olin J, Puschett J, Rosenfield K, Sacks D, Stanley J, Taylor L, White C, White J, White R, Antman E, Smith S, Adams C, Andreson J, Faxon D, Fuster V, Gibbons R, Halperin J, Hunt S, Jacobs A, Nishimura R, Ornato J, Page R, Riegel B. ACC/AHA 2005 Guidelines for the management of patients with peripheral arterial disease. J Am Coll Cardiol 2006; 47: e1-e192.
13. Nylaende M, Kroese A, Stranden E, Morken B, Sandbaek G, Lindahl A, Arnesen H, Seljeflot I. Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive disease. Vasc Med 2006; 11: 21-28.
14. Basarici I, Altekin R, Demir I, Yilmaz H. Urinary 8-isoprostane levels can predict the presence, severity and extent of angiographic coronary artery disease. Acta Cardiol 2008; 63: 415-422.
15. Isoda K, Kamezawa Y, Ayaori M, Kusuhara M, Tada N, Ohsuzu F. Osteopontin transgenic mice fed with a high-cholesterol diet develop early fatty-streak lesions. Circulation 2003; 107: 679-681.
16. Sharman J, Lim R, Qasem A, Coombes J, Burgess M, Franco J, Garraphy P, Wilkinson I, Marwick T. Validation of a generalized transfer function to noninvasively derive central blood pressure during exercise. Hypertension 2006; 47: 1203-1208.
17. Wilkinson I, Fuchs S, Jansen I, Spratt J, Murray G, Cockcroft J, Webb D. The reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998; 16: 2079-2084.
18. Nakagawa N, Takahashi F, Chinda J, Kobayashi M, Hayashi Y, Abe M, Saijo Y, Kikuchi K, Hasebe N. A newly estimated glomerular filtration rate is independently associated with arterial stiffness in Japanese patients. Hypertens Res 2008; 31: 193-201.
19. Bazzichi L, Ghiadoni L, Rossi A, Bernardini M, Lanza M, De Feo F, Giacomelli C, Mencaroni I, Raimo K, Rossi M, Mazzone A, Taddei S, Bombardieri S. Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis. Mol Med 2009; 15: 402-406.
20. Isoda K, Nishikawa K, Kamezawa Y, Yoshida M, Kusuhara M, Moroi M, Tada N, Ohsuzu F. Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ Res 2002; 91: 77-82.
21. Wada T, McKee M, Steitz S, Giachelli C. Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 1999; 84: 166-178.
22. Zagura M, Serg M, Kampus P, Zilmer M, Eha J, Unt E, Lieberg J, Cockcroft J, Kals J. Aortic stiffness and vitamin D are independent markers of aortic calcification in patients with peripheral arterial disease and in healthy subjects. Eur J Vasc Endovasc Surg 2011; 42: 689-695.
23. Zagura M, Serg M, Kampus P, Zilmer M, Zilmer K, Eha J, Unt E, Lieberg J, Kals J. Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects. Am J Hypertens 2010; 23: 586-591.
24. de Kleijn D, Moll F, Hellings W, Ozsarlak-Sozer G, de Bruin P, Doevendans P, Vink A, Catanzariti L, Schoneveld A, Algra A, Daemen M, Biessen E, de Jager W, Zhang H, de Vries J, Falk E, Lim S, van der Spek P, Sze S, Pasterkamp G. Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events. Arterioscler Thromb Vasc Biol 2010; 30: 612-619.
25. Patel R, Al Mheid I, Morris A, Ahmed Y, Kavtaradze N, Ali S, Dabhadkar K, Brigham K, Hooper W, Alexander R, Jones D, Quyyumi A. Oxidative stress is associated with impaired arterial elasticity. Atherosclerosis 2011; 218: 90-95.
26. Zieman S, Melenovsky V, Kass D. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 932-943.
27. Lind L. Arterial stiffness, but not endothelium-dependent vasodilatation, is related to a low ankle-brachial index. Clin Physiol Funct Imaging 2011; 31: 182-187.
28. Pannier B, Guerin A, Marchais S, Safar M, London G. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension 2005; 45: 592-596.